| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745291 | Parkinsonism & Related Disorders | 2014 | 5 Pages |
Abstract
PD-MCI is a significant, independent factor contributing to poorer QoL in patients with newly diagnosed PD. Those classified with greatest impairment (2.0 SD below normal values) have lower QoL. This has implications for clinical practice and future interventions targeting cognitive impairments.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, Tien K. Khoo, David P. Breen, Roger A. Barker, Daniel Collerton, John-Paul Taylor, David J. Burn,